A Pilot Trial of Pembrolizumab plus Prostatic Cryotherapy for Men with Newly Diagnosed Oligometastatic Hormone-Sensitive Prostate Cancer

BACKGROUND: Monotherapy with immune checkpoint inhibitors has generally been unsuccessful in men with advanced prostate cancer. Pre-clinical data support the notion that cryotherapy may improve immune-mediated and anti-tumor responses. The objective of this study was to assess the safety and feasibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Ashley E., Hurley, Paula J., Tran, Phuoc T., Rowe, Steven P., Benzon, Benjamin, O’Neal, Tanya, Chapman, Carolyn, Harb, Rana, Milman, Yelena, Trock, Bruce J., Drake, Charles G., Antonarakis, Emmanuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031012/
https://www.ncbi.nlm.nih.gov/pubmed/31611635
http://dx.doi.org/10.1038/s41391-019-0176-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031012/
https://www.ncbi.nlm.nih.gov/pubmed/31611635
http://dx.doi.org/10.1038/s41391-019-0176-8

Ejemplares similares